BRPI0519327A2 - processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica - Google Patents
processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊuticaInfo
- Publication number
- BRPI0519327A2 BRPI0519327A2 BRPI0519327-3A BRPI0519327A BRPI0519327A2 BR PI0519327 A2 BRPI0519327 A2 BR PI0519327A2 BR PI0519327 A BRPI0519327 A BR PI0519327A BR PI0519327 A2 BRPI0519327 A2 BR PI0519327A2
- Authority
- BR
- Brazil
- Prior art keywords
- salicylamide
- unsubstituted
- compound
- pharmaceutical composition
- preparation process
- Prior art date
Links
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical class NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229960000581 salicylamide Drugs 0.000 title 1
- XRTHAPZDZPADIL-UHFFFAOYSA-N 8-[(5-chloro-2-hydroxybenzoyl)amino]octanoic acid Chemical compound OC(=O)CCCCCCCNC(=O)C1=CC(Cl)=CC=C1O XRTHAPZDZPADIL-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 N-substituted salicylamides Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- BWAUQTFFVCLSOS-UHFFFAOYSA-N sodiosodium hydrate Chemical compound O.[Na].[Na] BWAUQTFFVCLSOS-UHFFFAOYSA-N 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427603.6A GB0427603D0 (en) | 2004-12-16 | 2004-12-16 | Organic compounds |
| PCT/EP2005/013454 WO2006063821A1 (en) | 2004-12-16 | 2005-12-14 | Manufacture process of n-substituted salicylamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0519327A2 true BRPI0519327A2 (pt) | 2009-01-13 |
Family
ID=34090175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0519327-3A BRPI0519327A2 (pt) | 2004-12-16 | 2005-12-14 | processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8461385B2 (enExample) |
| EP (2) | EP2955171A1 (enExample) |
| JP (1) | JP5224816B2 (enExample) |
| KR (1) | KR101287233B1 (enExample) |
| CN (1) | CN101080384B (enExample) |
| AR (1) | AR055007A1 (enExample) |
| AU (1) | AU2005315850B2 (enExample) |
| BR (1) | BRPI0519327A2 (enExample) |
| CA (1) | CA2587213C (enExample) |
| ES (1) | ES2547349T3 (enExample) |
| GB (1) | GB0427603D0 (enExample) |
| GT (1) | GT200500353A (enExample) |
| IL (1) | IL183366A0 (enExample) |
| MA (1) | MA29092B1 (enExample) |
| MX (1) | MX2007007211A (enExample) |
| NO (1) | NO338969B1 (enExample) |
| PE (1) | PE20060740A1 (enExample) |
| PL (1) | PL1838664T3 (enExample) |
| PT (1) | PT1838664E (enExample) |
| RU (1) | RU2404158C2 (enExample) |
| TN (1) | TNSN07229A1 (enExample) |
| TW (1) | TW200635880A (enExample) |
| WO (1) | WO2006063821A1 (enExample) |
| ZA (1) | ZA200703826B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20070548A1 (es) * | 2005-09-19 | 2007-07-12 | Emisphere Tech Inc | Formas cristalinas de la sal de di-sodio del acido n-(5-clorosaliciloil)-8-aminocaprilico |
| US8022048B2 (en) | 2007-11-02 | 2011-09-20 | Emisphere Technologies, Inc. | Method of treating vitamin B12 deficiency |
| CN109473182B (zh) * | 2018-11-12 | 2021-10-19 | 北京北排科技有限公司 | 一种基于深度信念网络的mbr膜透水率智能检测方法 |
| AU2020277650B2 (en) * | 2019-05-20 | 2025-03-13 | Lonza Guangzhou Pharmaceutical Ltd. | Method for preparation of carsalam |
| CN115260116B (zh) * | 2022-08-19 | 2024-04-12 | 株洲壹诺生物技术有限公司 | 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU382610A1 (ru) * | 1968-07-08 | 1973-05-25 | Способ получения амидов карбоновых кислот | |
| NZ534409A (en) | 1999-04-05 | 2006-03-31 | Emisphere Tech Inc | Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| KR20020013936A (ko) * | 1999-06-25 | 2002-02-21 | 추후제출 | 치환된 페녹시아세트산 |
| JP4799794B2 (ja) * | 2000-03-21 | 2011-10-26 | エミスフェアー・テクノロジーズ・インク | ジカルボキシル化中間体を介してアルキル化サリチルアミドを調製する方法。 |
| AU2001275231A1 (en) | 2000-06-02 | 2001-12-11 | Emisphere Technologies, Inc. | Method of preparing salicylamides |
| WO2003057650A2 (en) * | 2002-01-09 | 2003-07-17 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| NZ523017A (en) * | 2000-06-29 | 2004-10-29 | Emisphere Tech Inc | Compounds and compositions for delivering active agents and preparation method thereof |
| AU2001296865A1 (en) * | 2000-09-06 | 2002-03-22 | Emisphere Technologies, Inc. | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| AU2003208945B2 (en) * | 2002-02-20 | 2008-05-01 | Emisphere Technologies, Inc | Method for administering GLP-1 molecules |
| US20050054557A1 (en) * | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
-
2004
- 2004-12-16 GB GBGB0427603.6A patent/GB0427603D0/en not_active Ceased
-
2005
- 2005-12-02 GT GT200500353A patent/GT200500353A/es unknown
- 2005-12-14 WO PCT/EP2005/013454 patent/WO2006063821A1/en not_active Ceased
- 2005-12-14 PL PL05818421T patent/PL1838664T3/pl unknown
- 2005-12-14 RU RU2007126972/04A patent/RU2404158C2/ru not_active IP Right Cessation
- 2005-12-14 MX MX2007007211A patent/MX2007007211A/es active IP Right Grant
- 2005-12-14 CN CN2005800431247A patent/CN101080384B/zh not_active Expired - Fee Related
- 2005-12-14 PT PT58184219T patent/PT1838664E/pt unknown
- 2005-12-14 CA CA2587213A patent/CA2587213C/en not_active Expired - Fee Related
- 2005-12-14 ES ES05818421.9T patent/ES2547349T3/es not_active Expired - Lifetime
- 2005-12-14 EP EP15170908.6A patent/EP2955171A1/en not_active Withdrawn
- 2005-12-14 KR KR1020077013580A patent/KR101287233B1/ko not_active Expired - Fee Related
- 2005-12-14 BR BRPI0519327-3A patent/BRPI0519327A2/pt not_active Application Discontinuation
- 2005-12-14 AU AU2005315850A patent/AU2005315850B2/en not_active Ceased
- 2005-12-14 US US11/721,817 patent/US8461385B2/en not_active Expired - Fee Related
- 2005-12-14 JP JP2007545942A patent/JP5224816B2/ja not_active Expired - Fee Related
- 2005-12-14 EP EP05818421.9A patent/EP1838664B1/en not_active Expired - Lifetime
- 2005-12-14 AR ARP050105245A patent/AR055007A1/es not_active Application Discontinuation
- 2005-12-14 PE PE2005001448A patent/PE20060740A1/es not_active Application Discontinuation
- 2005-12-15 TW TW094144576A patent/TW200635880A/zh unknown
-
2007
- 2007-05-11 ZA ZA200703826A patent/ZA200703826B/xx unknown
- 2007-05-21 IL IL183366A patent/IL183366A0/en unknown
- 2007-06-11 MA MA29983A patent/MA29092B1/fr unknown
- 2007-06-15 TN TNP2007000229A patent/TNSN07229A1/fr unknown
- 2007-07-09 NO NO20073548A patent/NO338969B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN07229A1 (en) | 2008-11-21 |
| NO338969B1 (no) | 2016-11-07 |
| GB0427603D0 (en) | 2005-01-19 |
| AR055007A1 (es) | 2007-08-01 |
| CN101080384B (zh) | 2011-06-15 |
| CN101080384A (zh) | 2007-11-28 |
| PL1838664T3 (pl) | 2016-04-29 |
| JP2008524142A (ja) | 2008-07-10 |
| NO20073548L (no) | 2007-09-17 |
| EP1838664B1 (en) | 2015-07-15 |
| WO2006063821A1 (en) | 2006-06-22 |
| KR101287233B1 (ko) | 2013-07-17 |
| CA2587213A1 (en) | 2006-06-22 |
| US20090253811A1 (en) | 2009-10-08 |
| PT1838664E (pt) | 2015-10-16 |
| MX2007007211A (es) | 2007-08-15 |
| KR20070086276A (ko) | 2007-08-27 |
| EP1838664A1 (en) | 2007-10-03 |
| US8461385B2 (en) | 2013-06-11 |
| TW200635880A (en) | 2006-10-16 |
| GT200500353A (es) | 2006-07-17 |
| AU2005315850B2 (en) | 2009-11-05 |
| ES2547349T3 (es) | 2015-10-05 |
| AU2005315850A1 (en) | 2006-06-22 |
| PE20060740A1 (es) | 2006-09-04 |
| IL183366A0 (en) | 2007-09-20 |
| CA2587213C (en) | 2015-05-19 |
| MA29092B1 (fr) | 2007-12-03 |
| RU2404158C2 (ru) | 2010-11-20 |
| ZA200703826B (en) | 2008-08-27 |
| EP2955171A1 (en) | 2015-12-16 |
| RU2007126972A (ru) | 2009-01-27 |
| JP5224816B2 (ja) | 2013-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0211289A (pt) | Derivados de dolastatina 10 | |
| TR200201874T2 (tr) | Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler. | |
| BR0314113A (pt) | Derivados de amino propanol | |
| BR0309743A (pt) | Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados | |
| BR0112538A (pt) | Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos | |
| BR0313160A (pt) | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto | |
| BRPI0500585A (pt) | Processo para a sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
| CY1117449T1 (el) | Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων | |
| TNSN07228A1 (en) | Manufacture process of organic compounds | |
| UY27619A1 (es) | Ésteres hidroxamato del ácido n-(4-fenil sustituido)- antranílico | |
| BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
| BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
| BRPI0417609B8 (pt) | derivados de 3-ciano-quinolina com atividade antiproliferativa, seu processo de preparação e uso e composição farmacêutica que os compreende | |
| TNSN07229A1 (en) | Manufacture process of n-substituted salicylamides | |
| IL189015A0 (en) | Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid | |
| UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
| DK1255757T3 (da) | Aminosyreforbindelser og deres anvendelse som inhibitorer for NEP, ACE og ECE | |
| BR0214742A (pt) | Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação | |
| BR0115755A (pt) | Processo para preparação de ácido 1-(aminometil) ciclohexano-acético | |
| BR0307009A (pt) | Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii | |
| AR045727A1 (es) | Fluorocombretastatina y derivados de la misma | |
| ATE295845T1 (de) | Prucaloprid-n-oxid | |
| DK1585728T3 (da) | Iminosyrederivater som inhibitorer af matrix-metalloproteinaser | |
| BR0010658A (pt) | Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida | |
| MXPA03001985A (es) | Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |